Abvc Biopharma Inc Expected To Post A Loss Of 5 Cents A Share: Earnings Preview

ABVC Biopharma

12/05/2023 12:52

* ABVC Biopharma Inc  ABVC.OQ   ABVC.O  is expected to show
a fall
in quarterly revenue when it reports  results on May 15
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for ABVC Biopharma Inc
is for
a loss of 5 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ABVC
Biopharma
Inc is $2.02​, above​ its last closing price of $0.78. ​​​

This summary was machine generated May 12 at 11:52 GMT.  All
figures in US dollars  unless otherwise stated